Lifei Gu, MSc

Takeda Pharmaceutical Company, Shanghai, China, China

Poster(s):

• P3243 - Vedolizumab Demonstrated Effectiveness in Improving Symptom Relief and Quality of Life in Chinese Patients With Ulcerative Colitis: Results from the Real-World VALUE Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT